Author
Listed:
- Zhengkui Zhang
(Zhejiang University)
- Yao Fan
(Zhejiang University)
- Feng Xie
(Soochow University)
- Hang Zhou
(Zhejiang University)
- Ke Jin
(Zhejiang University)
- Li Shao
(The First Affiliated Hospital, School of Medicine, Zhejiang University, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease)
- Wenhao Shi
(Beijing Proteome Research Center, Beijing Institute of Radiation Medicine
National Center for Protein Sciences (The PHOENIX Center, Beijing)
State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, Fudan University)
- Pengfei Fang
(Zhejiang University)
- Bing Yang
(University of California San Francisco, San Francisco)
- Hans van Dam
(Leiden University Medical Center, Postbus 9600)
- Peter ten Dijke
(Leiden University Medical Center, Postbus 9600)
- Xiaofeng Zheng
(Metastasis Research Center, University of Texas MD Anderson Cancer Center)
- Xiaohua Yan
(Tsinghua University)
- Junling Jia
(Zhejiang University)
- Min Zheng
(The First Affiliated Hospital, School of Medicine, Zhejiang University, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease)
- Jin Jin
(Zhejiang University)
- Chen Ding
(Beijing Proteome Research Center, Beijing Institute of Radiation Medicine
National Center for Protein Sciences (The PHOENIX Center, Beijing)
State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, Fudan University)
- Sheng Ye
(Zhejiang University)
- Fangfang Zhou
(Soochow University)
- Long Zhang
(Zhejiang University)
Abstract
Metastasis is the main cause of death in cancer patients. TGF-β is pro-metastatic for malignant cancer cells. Here we report a loss-of-function screen in mice with metastasis as readout and identify OTUD1 as a metastasis-repressing factor. OTUD1-silenced cancer cells show mesenchymal and stem-cell-like characteristics. Further investigation reveals that OTUD1 directly deubiquitinates the TGF-β pathway inhibitor SMAD7 and prevents its degradation. Moreover, OTUD1 cleaves Lysine 33-linked poly-ubiquitin chains of SMAD7 Lysine 220, which exposes the SMAD7 PY motif, enabling SMURF2 binding and subsequent TβRI turnover at the cell surface. Importantly, OTUD1 is lost in multiple types of human cancers and loss of OTUD1 increases metastasis in intracardial xenograft and orthotopic transplantation models, and correlates with poor prognosis among breast cancer patients. High levels of OTUD1 inhibit cancer stemness and shut off metastasis. Thus, OTUD1 represses breast cancer metastasis by mitigating TGF-β-induced pro-oncogenic responses via deubiquitination of SMAD7.
Suggested Citation
Zhengkui Zhang & Yao Fan & Feng Xie & Hang Zhou & Ke Jin & Li Shao & Wenhao Shi & Pengfei Fang & Bing Yang & Hans van Dam & Peter ten Dijke & Xiaofeng Zheng & Xiaohua Yan & Junling Jia & Min Zheng & J, 2017.
"Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7,"
Nature Communications, Nature, vol. 8(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-02029-7
DOI: 10.1038/s41467-017-02029-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-02029-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.